239 related articles for article (PubMed ID: 37709921)
21. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells.
Kim HS; Lee EH; Ko SR; Choi KJ; Park JH; Im DS
Arch Pharm Res; 2004 Apr; 27(4):429-35. PubMed ID: 15180309
[TBL] [Abstract][Full Text] [Related]
22. Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review).
Zhang H; Park S; Huang H; Kim E; Yi J; Choi SK; Ryoo Z; Kim M
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649861
[TBL] [Abstract][Full Text] [Related]
23. Antitumoral Activity of (20R)- and (20S)-Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice.
Lv Q; Rong N; Liu LJ; Xu XL; Liu JT; Jin FX; Wang CM
Planta Med; 2016 May; 82(8):705-11. PubMed ID: 27163230
[TBL] [Abstract][Full Text] [Related]
24. Anticancer Effects of Ginsenoside Rh2: A Systematic Review.
He XL; Xu XH; Shi JJ; Huang M; Wang Y; Chen X; Lu JJ
Curr Mol Pharmacol; 2022; 15(1):179-189. PubMed ID: 33687905
[TBL] [Abstract][Full Text] [Related]
25. Production of the Rare Ginsenoside Rh2-MIX (20(
Song BK; Kim KM; Choi KD; Im WT
J Microbiol Biotechnol; 2017 Jul; 27(7):1233-1241. PubMed ID: 28478658
[TBL] [Abstract][Full Text] [Related]
26. Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2.
Popovich DG; Kitts DD
Can J Physiol Pharmacol; 2004 Mar; 82(3):183-90. PubMed ID: 15052284
[TBL] [Abstract][Full Text] [Related]
27. Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells.
Zhang J; Zhou F; Wu X; Zhang X; Chen Y; Zha BS; Niu F; Lu M; Hao G; Sun Y; Sun J; Peng Y; Wang G
Br J Pharmacol; 2012 Jan; 165(1):120-34. PubMed ID: 21615726
[TBL] [Abstract][Full Text] [Related]
28. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis.
Gao H; Liang D; Li C; Xu G; Jiang M; Li H; Yin J; Song Y
Biomed Pharmacother; 2020 Apr; 124():109891. PubMed ID: 31991384
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models.
Bae EA; Han MJ; Shin YW; Kim DH
Biol Pharm Bull; 2006 Sep; 29(9):1862-7. PubMed ID: 16946499
[TBL] [Abstract][Full Text] [Related]
30. Characterizing the mechanism for ginsenoside-induced cytotoxicity in cultured leukemia (THP-1) cells.
Kitts DD; Popovich DG; Hu C
Can J Physiol Pharmacol; 2007 Nov; 85(11):1173-83. PubMed ID: 18066119
[TBL] [Abstract][Full Text] [Related]
31. Research Progress on the Antitumor Molecular Mechanism of Ginsenoside Rh2.
Yang L; Chen JJ; Sheng-Xian Teo B; Zhang J; Jiang M
Am J Chin Med; 2024; 52(1):217-230. PubMed ID: 38291582
[TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rh2 Improves the Cisplatin Anti-tumor Effect in Lung Adenocarcinoma A549 Cells via Superoxide and PD-L1.
Chen Y; Zhang Y; Song W; Zhang Y; Dong X; Tan M
Anticancer Agents Med Chem; 2020; 20(4):495-503. PubMed ID: 31814556
[TBL] [Abstract][Full Text] [Related]
33. Production of aglycon protopanaxadiol via compound K by a thermostable β-glycosidase from Pyrococcus furiosus.
Yoo MH; Yeom SJ; Park CS; Lee KW; Oh DK
Appl Microbiol Biotechnol; 2011 Feb; 89(4):1019-28. PubMed ID: 21052989
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in silico evaluation of stereoselective effect of ginsenoside isomers on platelet P2Y
Yang Q; Wang N; Zhang J; Chen G; Xu H; Meng Q; Du Y; Yang X; Fan H
Phytomedicine; 2019 Nov; 64():152899. PubMed ID: 31454649
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Proteomics Combined with Affinity MS Revealed the Molecular Mechanism of Ginsenoside Antitumor Effects.
Wang Z; Kim U; Jiao Y; Li C; Guo Y; Ma X; Jiang M; Jiang Z; Hou Y; Bai G
J Proteome Res; 2019 May; 18(5):2100-2108. PubMed ID: 30860844
[TBL] [Abstract][Full Text] [Related]
36. Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation.
Xiaodan S; Ying C
Biomed Pharmacother; 2022 Dec; 156():113912. PubMed ID: 36288668
[TBL] [Abstract][Full Text] [Related]
37. Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy.
Jia WW; Bu X; Philips D; Yan H; Liu G; Chen X; Bush JA; Li G
Can J Physiol Pharmacol; 2004 Jul; 82(7):431-7. PubMed ID: 15389289
[TBL] [Abstract][Full Text] [Related]
38. [Induction of differentiation by ginsenoside Rh2 in hepatocarcinoma cell SMMC-7721].
Zeng XL; Tu ZG
Ai Zheng; 2004 Aug; 23(8):879-84. PubMed ID: 15301707
[TBL] [Abstract][Full Text] [Related]
39. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Chen W; Qiu Y
Cell Biochem Biophys; 2015 Jun; 72(2):325-31. PubMed ID: 25561284
[TBL] [Abstract][Full Text] [Related]
40. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants.
Bae EA; Han MJ; Kim EJ; Kim DH
Arch Pharm Res; 2004 Jan; 27(1):61-7. PubMed ID: 14969341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
